Conclusion

The export intensity of Indian pharmaceutical firms has increased substantially in the period after 1995 when the new, more restrictive patent regime was introduced in India. The hike in export intensity has been accompanied by an increase in R&D intensity of Indian pharmaceutical firms. The results of the analysis presented in the paper provide support to the hypothesis that increased R&D efforts of pharmaceutical firms was one of the important factors responsible for the observed increase in export intensity.